Beacon Pharmaceuticals Limited, the leading oncology company in Bangladesh, has introduced a groundbreaking treatment for lung cancer: Tagrix, the first global generic version of osimertinib.
Creating Sustainable Values for The Society
BEACON takes pride as a Bangladeshi company involved in a diverse range of Corporate Social Responsibility (CSR)